highly significantP < 0.001
The higher proportion of infants with protective levels of anti-HBs in the TDF-BF Group, although initially borderline statistically significant ( P = 0.046) at 12 months, demonstrated a highly significant and sustained benefit at the three-year follow-up (92.7% vs. 75.0%, P < 0.001).